For context, here's a clean comparison: Semaglutide 2.4 mg: ~15% body weight loss (68 weeks, Phase 3) Tirzepatide 15 mg: ~21% body weight loss (72 weeks, Phase 3) Retatrutide 12 mg: ~24% body weight loss (48 weeks, Phase 2) The trajectory is clear
J.et al (2016)
Severe GERD may present with respiratory symptoms including chronic cough, throat clearing, and a sensation of breathlessness, particularly when lying down
Cleveland Clinic Rolls Out AI for Documentation : Cleveland Clinic has started deploying Ambience Healthcares AI platform to streamline clinical documentation
In practical terms: Tirzepatide offers well-documented, steady metabolic support and weight-loss results
Therefore, the results and conclusions from these NAFLD-based trials remain relevant to MASLD populations